A carregar...
Benzydamine inhibits osteoclast differentiation and bone resorption via down-regulation of interleukin-1β expression
Bone diseases such as osteoporosis and periodontitis are induced by excessive osteoclastic activity, which is closely associated with inflammation. Benzydamine (BA) has been used as a cytokine-suppressive or non-steroidal anti-inflammatory drug that inhibits the production of pro-inflammatory cytoki...
Na minha lista:
| Publicado no: | Acta Pharm Sin B |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7049613/ https://ncbi.nlm.nih.gov/pubmed/32140392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2019.11.004 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|